cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccine
Unique antigens for therapeutic cancer vaccines reviewed
December 14th, 2004
A researcher reviews unique antigens for therapeutic cancer vaccines in a recent issue of the Proceedings of the National Academy of Sciences of the United States of America. According to a study from the United States, "A decade ago, it seemed rational that our rapidly increasing knowledge of the molecular identities of tumor antigens and a deeper understanding of basic immunology would point the way to an effective therapeutic cancer vaccine. Significant progress has been made, but we do not yet have a cancer vaccine that can reliably and consistently induce tumor destruction or improve patient survival. Random mutations in cancer cells generate unique antigens...
Source: cancer weekly (2004-12-14)
|
